info@marketresearchfuture.com   đź“ž  +1 (855) 661-4441(US)   đź“ž  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Buergers Disease Market Share

ID: MRFR//2698-HCR | 82 Pages | Author: Kinjoll Dey| November 2024

Cost leadership is adopted by firms that emphasize low cost to provide more people with access to health care. This means of producing treatment methods at lower prices hence making them affordable to many patients relies on efficiency that streamlines production processes. Manufacturing operations need rationalizing, favorable supplier contracts should be negotiated, as well as distribution systems becoming cheap. This provision of affordable options satisfies patients’ financial concerns while creating competitive positions for corporations involved.
When a company is trying to increase its market share in the existing market, it can consider opting for market penetration. This basically involves increasing efforts in promoting their existing products, engaging specific marketing campaigns and ensuring healthcare professionals collaborate with them to promote the use of their Buerger's Disease treatments. Companies that capture a larger portion of the current market are able to have economies of scale as well as obtain valuable insights about consumer preferences while also becoming thought leaders in addressing Buerger’s Disease challenges.
On the other hand, market development strategies focus on expanding into new geographic areas or customer segments for Buerger's Disease Market. Such may include adaptation of existing treatments for diverse patient populations’ needs or entering untapped markets where demand for Buerger's Disease management solutions exist. Diversification of consumers’ bases, reducing reliance on particular markets and exploiting emerging opportunities within the Buerger’s Disease treatment landscape come through this platform.
Additionally, Patient experience and building strong relationships with health care providers remain central. It enhances educational resources availability, support services presence and ensuring effective communication all contribute toward general value proposition of any company’s Buerger's Disease treatments. Therefore, not only specific therapies' success relies on patients' satisfaction and trust but also a positive reputation is established within the Buerger's disease market.

Covered Aspects:

Report Attribute/Metric Details
Base Year For Estimation   2021
Forecast Period   2022-2030
Growth Rate   5.9% (2022-2030)

Global Buerger’s Disease Market Overview


The Buerger’s Disease Market is anticipated to reach USD 592.6 Million by 2030 at 5.9% CAGR during the forecast period 2022-2030.


Buerger’s Disease Market


Buerger’s disease is also known as thromboangiitis obliterans (TAO). Buerger’s disease is a rare and severe disease of veins and arteries especially in arms and legs. In this disease, blockage of blood vessels of hands and feet occurs in this disease condition. Blood clots or thrombi obstruct the blood vessels, resultantly, the blood vessels become inflamed and swell which reduces the blood flow. 


This leads to the destruction or damage of skin tissues that may cause gangrene and other infections. The exact causes of this disease are unknown but tobacco is believed to be responsible to an extent, in the development of this disease. Some major symptoms of this disease are pain in feet and arms, inflammation, Raynaud's phenomenon etc. There is no 100% cure for this disease.


Considering the market scenario of Buerger’s disease, some important factors are driving the growth for this market one of them is increasing investment in research, development of new therapies and clinical trials. Approvals for new treatments or therapies plays vital role in the growth of this market. 


In 2016, the Indian company named STEMPEUTICS RESEARCH PVT LTD got limited approval from the Drugs Controller General (India) for commercialization of stem cell based biological product Stempeucel for the treatment of Buerger's Disease. Germany based company named t2cure GmbH also initiated a pivotal clinical study for Buerger's disease. Introduction and adoption of advanced diagnostic medical devices are another key drivers for the Buerger’s disease market growth.


Top Key players in the Buerger’s Disease Market are


Some of the key players in this market are: 



  • FUJIFILM Holdings Corporation (Japan)

  • General Electric Company (US)

  • Koninklijke Philips N.V. (the Netherlands)

  • Pluristem (Israel)

  • Shimadzu Corporation (Japan)

  • Siemens Healthcare GmbH (Germany)

  • STEMPEUTICS RESEARCH PVT LTD (India) 

  • Toshiba Medical Corporation (Japan)

  • T2Cure GmbH (Germany)


Buerger Disease Market Segment Insights  


Buerger Disease Diagnosis Insights


Buerger’s disease market has been segmented on the basis of diagnosis which comprise of blood tests, The Allen's test, angiogram, tissue biopsy, and others. Angiogram is further sub-segmented into CT scan (Computerized Tomography), MRI (Magnetic Resonance Imaging) Scan, X-rays, and others.


Buerger Disease Treatments Insights


On the basis of treatments, the market has been segmented into smoking cessation, and other treatments. Other treatments is further sub-segmented into medications, intermittent compression of the arms and legs, spinal cord stimulation, surgery, amputation, therapeutic angiogenesis, and others. Medication includes medications to dilate blood vessels, medications to improve blood flow, medications to dissolve blood clots, and others.


 


Buerger Disease End User Insights


On the basis of end user, it is segmented into hospital and clinics, medical research centers, academic institutes, and others.


Research Methodology:


Regional analysis of Buerger’s disease market:      


Considering the global scenario of the market, the Americas are holding the largest market for Buerger’s disease. The Americas mainly include North America and Latin America, out of which North America is holding majority of market share of this region. US is the top revenue generating market in North America and is one of the important markets for Buerger’s disease. Various factors are leading the market growth such as availability of funding for research and clinical trials, and advanced diagnostic and treatment options. Latin America Buerger’s disease market is also growing significantly and mainly includes Brazil, Argentina and Chile.  


Europe is the second largest and one of the important markets for Buerger’s disease. Increasing cases of Buerger’s disease is a key driving factor for this market. Europe is mainly divided into Eastern Europe and Western Europe. 


More developed western European countries like Germany, UK and France are dominating this market while East European region is also growing significantly. Asia Pacific region is showing the fastest growth rate in Buerger’s disease market due to some major factors such as increasing awareness of the disease and related care, increasing investment in research, and rapidly improving healthcare facilities. China is holding major market share while India market is expected to have fastest growth in this region. Governments of different Asia nations are taking various initiatives to increase awareness of this disease that plays important role in the growth of this market. 


Middle East & Africa is expected to have a limited growth due to lack of knowledge of disease, traditional healthcare practices etc. Middle East region is dominating this market due to some major factors like developed healthcare facilities and government support to improve public health.


Intended Audience:



  • Buerger’s disease diagnostic and treatment supplies companies

  • Buerger’s disease diagnostic and treatment supplies providers

  • Medical research laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.